Pediatric Healthcare Market Size, Share Report, Analysis, Trends, Growth 2032

Pediatric Healthcare Market

Pediatric Healthcare Market By Type (Chronic Illness and Acute Illness), By Indication (Asthma and Allergies, Metabolic Disorders, Cardiac Disorders, Genetic Disorders, and Others), and By Treatment (Immunotherapy, Medications, Surgeries, and Others), and By Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024–2032-

Category: Healthcare Report Format : PDF Pages: 207 Report Code: ZMR-4474 Published Date: Aug-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 13.10 Billion USD 19.14 Billion 4.3% 2023

Pediatric Healthcare Market Industry Prospective

The global Pediatric Healthcare Market size was valued at USD 13.10 Billion in 2023 and is predicted to reach USD 19.14 Billion by the end of 2032. The market is expected to grow with a CAGR of 4.3% during the forecast period. The report analyzes the global Pediatric Healthcare Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Pediatric Healthcare industry.

Global Pediatric Healthcare Market SizeRequest Free Sample

Pediatric Healthcare Market: Overview

The report covers a forecast and an analysis of the pediatric healthcare market on a global and regional level. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million). The study includes the drivers and restraints of the pediatric healthcare market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pediatric healthcare market on a global and regional level.

In order to give the users of this report a comprehensive view of the pediatric healthcare market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Pediatrics is the branch of medicine that deals with the health, growth, and development of adolescents, infants, and children along with their chances of achieving the full potential as adults. It emphasizes on children’s well-being, right from conception to adolescence. The medical branch of pediatrics is categorized into various different sub-branches—pediatric immunology, pediatric dermatology, pediatric cardiology, pediatric oncology, and pediatric critical care. Pediatric healthcare mainly includes nutrition, vaccines, and drugs, which help children to grow up healthy. Pediatric care involves a broad range of health and development services, ranging from preventive healthcare to the diagnosis and treatment of acute and chronic diseases. Pediatric healthcare is a discipline concerning the social, biological, and environmental influences on a child and the impact of various diseases and dysfunctions on his/her overall development.

The global pediatric healthcare market is likely to grow notably, due to the exponential increase in the demand for chronic disease treatment, changes witnessed in childcare trends, increase in the obese population base due to sedentary lifestyle, rise in the number of hospitals and clinics, improvements in healthcare infrastructure in developing economies, high acceptance rate of pediatric healthcare, escalation in starvation among pediatric population, advancements in medical technology, and supportive government initiatives. However, the high treatment cost may limit the pediatric healthcare market growth globally.

Pediatric healthcare Market: Segmentation Analysis

The pediatric healthcare market is fragmented on the basis of type, indication, and treatment.

Based on type, the market is segmented into chronic illness and acute illness. The chronic illness segment held the largest market share in 2024, due to the increasing prevalence of chronic disease and growing treatment demand for diseases.

By indication, the market is categorized into cardiac disorders, asthma and allergies, genetic disorders, metabolic disorders, and others. Allergies and metabolic disorders together held the largest market shares in 2023, owing to the increasing obese population. The treatment segment includes immunotherapy, medication, surgeries, and others.

The report provides a company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the pediatric healthcare market on a global and regional basis.

Global Pediatric Healthcare Market Request Free Sample

Regional segment includes

North America dominated the global pediatric healthcare market with a major revenue share in 2024, due to the launch of new drugs by pharmaceutical companies for pediatric patients, increasing adoption of modern medical technology, and the regional presence of the key market players. North America is estimated to remain at the top position over the forecast period as well. Europe held the second spot in the global pediatric healthcare market in 2024, due to the increasing demand for chronic disease treatment and growing enterprises of medical hospitals and clinics. The Asia Pacific pediatric healthcare market will register the highest CAGR over the forecast time period, owing to the various improvement in the healthcare infrastructure and the increasing children population suffering from diseases and disorders.

Some key players operating in the global pediatric healthcare market are GlaxoSmithKline, AstraZeneca, Pfizer, Merck, Boehringer Ingelheim, Pediapharm, Sanofi, Gilead Sciences, Eisai, and Mylan.

Pediatric Healthcare Market: Report Scope

Report Attributes Report Details
Report Name Pediatric Healthcare Market
Market Size in 2023 USD 13.10 Billion
Market Forecast in 2032 USD 19.14 Billion
Growth Rate CAGR of 4.3%
Number of Pages 207
Key Companies Covered GlaxoSmithKline, AstraZeneca, Pfizer, Merck, Boehringer Ingelheim, Pediapharm, Sanofi, Gilead Sciences, Eisai, and Mylan
Segments Covered By type, By indication, By treatment and By region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Some key players operating in the global pediatric healthcare market are

  • GlaxoSmithKline
  • AstraZeneca
  • Pfizer
  • Merck
  • Boehringer Ingelheim
  • Pediapharm
  • Sanofi
  • Gilead Sciences
  • Eisai
  • and Mylan.

This report segments the global pediatric healthcare market into:

Global Pediatric Healthcare Market: By Type

  • Acute Illness
  • Chronic Illness

Global Pediatric Healthcare Market: By Indication

  • Asthma and Allergies
  • Metabolic Disorders
  • Cardiac Disorders
  • Genetic Disorders
  • Others

Global Pediatric Healthcare Market: By Treatment

  • Immunotherapy
  • Medications
  • Surgeries
  • Others

Global Pediatric Healthcare Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Pediatric Healthcare market size earned around $13.10 Bn in 2023 and is expected to reach $19.14 Bn by 2032,

The largest share of the Pediatric Healthcare market is held by Asia Pacific. Developing countries of Asia Pacific such as China, Japan, and India will be dominating the market scenario mainly due to the rising constructional activities. The growth of Asia-Pacific region is expected to be followed by the Middle East and North America. Also, significant growth is expected from Western Europe owing to the developments taking place in this region especially in countries such as Italy, Germany, the U.K, France, and Spain. However, growth in Africa, Latin America, and Eastern Europe is anticipated to be moderate over the forecast period.

GlaxoSmithKline, AstraZeneca, Pfizer, Merck, Boehringer Ingelheim, Pediapharm, Sanofi, Gilead Sciences, Eisai, and Mylan

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed